Raul Ayala
Impact in
- Oncology top 10%
- HER2/EGFR in Cancer Research
- Cancer-related Molecular Pathways
Papers in
-
- Ubiquitin and proteasome pathways 2
- Kruppel-like factors research 1
-
- Advanced Breast Cancer Therapies 5
- Co-authors
- Dennis J. Slamon (10 shared papers)Mark R. Bray (1 shared paper)Fairooz F. Kabbinavar (1 shared paper)Beth Y. Karlan (1 shared paper)Bryan E. Snow (1 shared paper)John F. Lyons (1 shared paper)Richard S. Finn (4 shared papers)Zev A. Wainberg (2 shared papers)
- Journals
- Cancer Research (5 papers)Molecular Cancer Therapeutics (3 papers)Clinical Cancer Research (1 paper)eLife (1 paper)Breast Cancer Research (1 paper)
- Partner nations
- United StatesAustraliaBelgium
In The Last Decade
Raul Ayala
17 papers receiving 813 citations
Peers
Comparison fields: 5 of 77
- Oncology 356
- Cancer Research 124
- Pulmonary and Respiratory Medicine 253
- Molecular Biology 483
- Genetics 64
Countries citing papers authored by Raul Ayala
This map shows the geographic impact of Raul Ayala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raul Ayala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raul Ayala more than expected).
Fields of papers citing papers by Raul Ayala
This network shows the impact of papers produced by Raul Ayala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raul Ayala. The network helps show where Raul Ayala may publish in the future.
Co-authors
The 25 scholars most cited alongside Raul Ayala, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Overexpression of AKT2/protein kinase Bbeta leads to up-regulation of beta1 integrins, increased invasion, and metastasis of human breast and ovarian cancer cells. | 2003 | 353 |
| 2 | 2010 | 171 | |
| 3 | 2020 | 87 | |
| 4 | 2013 | 68 | |
| 5 | 2013 | 58 | |
| 6 | 2014 | 38 | |
| 7 | 2021 | 12 | |
| 8 | 2006 | 12 | |
| 9 | 2023 | 8 | |
| 10 | 2023 | 5 | |
| 11 | 2019 | 5 | |
| 12 | 2017 | 4 | |
| 13 | 2021 | 3 | |
| 14 | 2022 | 2 | |
| 15 | 2021 | 2 | |
| 16 | 2019 | 1 | |
| 17 | 2019 | 1 | |
| 18 | 2023 | 0 |
About Raul Ayala
Raul Ayala is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Radiology, Nuclear Medicine and Imaging and Nephrology, having authored 18 papers that have together received 830 indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (5 papers), HER2/EGFR in Cancer Research (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Hippo pathway signaling and YAP/TAZ (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), Ubiquitin and proteasome pathways (2 papers), Peptidase Inhibition and Analysis (2 papers) and Kruppel-like factors research (1 paper). The work is most often cited by research in Oncology (356 citations), Cancer Research (124 citations), Pulmonary and Respiratory Medicine (253 citations), Molecular Biology (483 citations) and Genetics (64 citations). Raul Ayala has collaborated with scholars based in United States, Australia and Belgium. Frequent co-authors include Dennis J. Slamon, Mark R. Bray, Fairooz F. Kabbinavar, Beth Y. Karlan, Bryan E. Snow, John F. Lyons, Richard S. Finn, Zev A. Wainberg, Amrita Desai and Tong Luo. Their work appears in journals such as Cancer Research, Molecular Cancer Therapeutics, Clinical Cancer Research, eLife and Breast Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.